Our physician office business for medical and laboratory products is now part of Henry Schein Medical — the world’s largest provider of health care products and services for office-based medical, dental, and animal health practitioners.
We offer a range of cost-efficient, clinician-preference items with low clinical differentiation.
We deliver the essential pharmaceuticals that care providers need to keep their patients healthy.
We give providers access to products and help manufacturers bring products to market effectively.
Looking ahead with the leading minds in healthcare.
Read expert commentary, best practices, and insights from the leaders who are shaping the industry.
Find articles that are relevant to your field of interest.
Learn more about how Cardinal Health is improving healthcare through our company history and facts, our diverse supplier base and business conduct standards, and our recent awards and innovation lab.
The DSCSA establishes a national system for tracing prescription drugs and combats counterfeiting and contamination.
On November 27, 2013, the Drug Quality and Security Act (H.R. 3204) was signed into law. Title II of the act – the Drug Supply Chain Security Act (DSCSA) – establishes a national system for tracing pharmaceutical products through the supply chain and sets national licensing standards for wholesale distributors and third-party logistics providers.
The legislation covers only prescription drugs in finished dosage form for human use; it excludes the following:
The legislation immediately pre-empted the patchwork of state pedigree laws and regulations. Cardinal Health worked across the supply chain to ensure a smooth transition from state pedigree compliance to federal compliance.
More details about the law are available on the FDA website.
©2017 Cardinal Health. All rights reserved.